Abstract:Xian Zhang, Jialu Bao, Yan Zhang, Xiaodan Wang College of Traditional Chinese Veterinary Medicine, Hebei Agricultural University, Baoding, 071001, People's Republic of China Correspondence: Xiaodan Wang, College of Traditional Chinese Veterinary Medicine, Agricultural University of Hebei Baoding, People's Republic of China, 071001, Email Background: Obesity is a growing global problem that causes various complications such as diabetes, cognitive dysfunction, cardiovascular diseases, and hepatobiliary disease. Alpha-linolenic acid (ALA) has been reported to exhibit multiple pharmaceutical effects. This study aimed to explore the effects of ALA on obesity-induced adipose tissue accumulation, cognitive impairment, inflammation, and colonic mucosal barrier integrity. Methods: Mice were fed with high-fat diet (HFD) and were treated with ALA (60 or 100 mg/kg). Body weight, adipose tissue, serum glucose and lipid levels, glucose resistance, and insulin resistance were measured. Cognitive ability was analyzed using the behavior tests. PTP1B and IRS/p-AKT/p-GSK3β/p-Tau signaling were examined to evaluate inflammation and synaptogenesis. Colon mucosal barrier integrity was examined by Alcian blue staining and expression of the tight junction proteins. The production of pro-inflammatory cytokines and liver damages were evaluated. 3T3-L1 cells were used for in vitro experiments. Cell viability, migration and invasion were detected. The levels of ROS, iron, and ferrous ions were measured to assess ferroptosis. Metabolomic analysis of adipose tissues was performed. Results: ALA treatment prevented HFD-induced adipose tissue accumulation, improved glucose and lipid homeostasis and metabolism. Administration of ALA repressed the HFD-induced increase in insulin levels and insulin resistance index. Serum and colon levels of pro-inflammatory cytokines were decreased after ALA treatment. ALA elevated mitochondrial content in brown adipose tissues. ALA ameliorated obesity-induced cognitive impairment and hippocampal inflammation, enhanced colon mucosa integrity. ALA treatment ameliorated HFD-induced liver damage and lipid accumulation and inhibited differentiation of preadipocyte 3T3-L1 cells into mature adipocytes and induces ferroptosis. Metabolomic analysis suggested that ALA may target the glycerolipid metabolism pathway to ameliorate obesity. Knockdown of AGPAT2 abolished the protective effects of ALA. Conclusion: ALA treatment suppressed adipose accumulation in adipocytes, improved cognitive ability and colon integrity, and alleviated liver damage by modulating the 1-acylglycerol-3-phosphate O-acyltransferase 2 (AGPAT2). Keywords: alpha-linolenic acid, obesity, liver damage, cognitive recognition, colon integrity Obesity has become a growing global problem and is regularly correlated with a wide spectrum of complications, including metabolic disorders, diabetes, cognitive dysfunction, cardiovascular diseases, hepatobiliary disease, and colon mucosal barrier impairment. 1–3 Obesity can cause grave financial, individual, and societal burdens in modern and future societies given its universal complications. 4 According to the World Health Organization (WHO), individuals with a body mass index (BMI) of > 30 kg/m2 are defined as obese. In recent decades, the number of overweight and obese populations has rapidly increased owing to high caloric intake, environmental factors, and unhealthy lifestyle. 4,5 Abnormal accumulation and dysfunction of adipose tissue is a universal phenomenon in obese individuals that leads to abnormal production of cytokines and hormones by adipocytes and consequently affects the functions of the liver, bone, colon, muscle, and nervous system. 6,7 Therefore, obesity is an urgent issue worldwide. Currently, the primary choice for tackling obesity is to strengthen physical activity and decrease energy intake, which are difficult for most people to maintain. Hence, it is necessary to explore pivotal regulatory mechanisms and identify effective therapies to alleviate obesity. Alpha-linolenic acid (ALA) is a plant-based omega-3 fatty acid that is one of the two essential fatty acids found in humans. 8 The only source of ALA in the human body is ingestion of food, followed by its conversion to docosahexaenoic acid and eicosapentaenoic acid. 9 This process is limited and regulated by various factors including disease and sex. 10,11 Accumulating evidence has suggested pharmacological implications of ALA, such as anti-inflammatory, anti-cancer, anti-metabolic, neuroprotective, and anti-obesity. 10–12 In this study, we investigated the effects of ALA on obesity-induced complications including glucose and lipid metabolism, cognitive impairment, -Abstract Truncated-

(+)Alpha-Lipoic Acid Regulates Lipid Metabolism Gene Expression and Lipidic Profile in a Cellular Model of Fatty Acid Overload

α-lipoic acid prevents non-alcoholic fatty liver disease in OLETF rats

(+)-Lipoic acid reduces mitochondrial unfolded protein response and attenuates oxidative stress and aging in an in vitro model of non-alcoholic fatty liver disease

(+)-Lipoic Acid Reduces Lipotoxicity and Regulates Mitochondrial Homeostasis and Energy Balance in an In Vitro Model of Liver Steatosis

Impact of combined therapy with alpha-lipoic and ursodeoxycolic acid on nonalcoholic fatty liver disease: double-blind, randomized clinical trial of efficacy and safety

Alpha lipoic acid administration improved both peripheral sensitivity to insulin and liver clearance of insulin reducing potential risk of diabetes and nonalcoholic fatty liver disease in overweight/obese PCOS patients

Alpha-lipoic acid supplementation increases the efficacy of exercise- and diet-induced obesity treatment and induces immunometabolic changes in female mice and women

Molecular and histological traits of reduced lysosomal acid lipase activity in the fatty liver

Alpha-lipoic Acid Improves High-Fat Diet-Induced Hepatic Steatosis by Modulating the Transcription Factors SREBP-1, FoxO1 and Nrf2 Via the SIRT1/LKB1/AMPK Pathway.

Hepatic-Metabolic Activity of α-Lipoic Acid—Its Influence on Sphingolipid Metabolism and PI3K/Akt/mTOR Pathway in a Rat Model of Metabolic Dysfunction-Associated Steatotic Liver Disease

Γ-Linolenic Acid Prevents Lipid Metabolism Disorder in Palmitic Acid-Treated Alpha Mouse Liver-12 Cells by Balancing Autophagy and Apoptosis Via the LKB1-AMPK-mTOR Pathway.

Alpha-lipoic Acid Attenuates Insulin Resistance and Improves Glucose Metabolism in High Fat Diet-Fed Mice

Alpha-Linolenic Acid Ameliorates Cognitive Impairment and Liver Damage Caused by Obesity

Targeting liver and adipose tissue in obese mice: Effects of a N-acylethanolamine mixture on insulin resistance and adipocyte reprogramming

Impact of dietary lipoic acid supplementation on liver mitochondrial bioenergetics and oxidative status on normally fed Wistar rats

5-ALA Ameliorates Hepatic Steatosis Through AMPK Signaling Pathway

Alpha-Lipoic Acid: Biological Mechanisms and Health Benefits

Diverse impact of N-acetylcysteine or alpha-lipoic acid supplementation during high-fat diet regime on fatty acid transporters in visceral and subcutaneous adipose tissue

Alantolactone attenuates high-fat diet-induced inflammation and oxidative stress in non-alcoholic fatty liver disease

Alantolactone Suppresses APOC3 Expression and Alters Lipid Homeostasis in L02 Liver Cells

Role of alpha-lipoic acid in vascular function: A systematic review of human intervention studies